The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic
about
Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyIron: a target for the management of Kaposi's sarcoma?The conundrum of causality in tumor virology: the cases of KSHV and MCVTwenty years of KSHVUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressMapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients.The challenge of AIDS-related malignancies in sub-Saharan Africa.Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings.An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrateReactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative populationābased sample in Uganda.Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic areaHigher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia.Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcomaThe Zambia Children's KS-HHV8 Study: rationale, study design, and study methods.Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells.Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South AfricaKaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects.AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.The pleiotropic effects of Kaposi's sarcoma herpesvirus.Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS.Non AIDS Kaposi's Sarcoma Leading to Lower Extremities Wounds, Case Presentations and Discussion.A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric PopulationRisk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices.Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmissionViral infections and human cancers: the legacy of Denis Burkitt.Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda.Human oncogenic viruses: nature and discovery.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
P2860
Q24804288-3DB066A8-B92A-4A39-8E18-3F8224F9AC5AQ24807119-A9A229FD-9399-42DF-9AAF-5605E602099CQ26863112-F9C7F11A-6116-4D18-81B4-FA0DB2EB0FE8Q26999889-C59F21C9-9E7D-48F9-A37A-5091021E308AQ28472699-2DA07AB5-7DF6-4605-8F60-266FBB041C97Q30251585-9CD219F3-93A3-46CE-B77D-367362A7363EQ30380999-E68FC635-C5D1-421B-B104-89D9BE015F00Q30387346-1AFDDD0E-B1A3-4E9A-BD12-EEE00091C996Q33523293-0E11866B-362D-4B6E-A2A6-21F18685EA42Q33618403-F4561D6E-AE8E-489E-9468-1A4A255084FFQ33702364-390F6E08-31C2-4EAD-A1C1-3ABCDBBC1731Q33717717-91F27B06-976C-4FC0-8D2A-421B7D6340BAQ33803534-2B8C9F73-7091-4029-84C7-6A3D25564466Q33952679-AE574FC6-A8A2-40FF-9228-689218F02B5CQ34172766-B678FE05-34D6-4ADC-B405-55A9CA57727DQ34446582-11ED8C56-7C00-4A79-878C-D0528A58E22BQ34783313-E176E9EE-4088-4AEB-A764-31894479F235Q34963626-79DB60E7-35D3-4D49-B697-63862041733EQ35056369-D62D7DA9-E2FA-4D13-B6C9-C16958126821Q35062684-B3C47035-6849-43A0-9F56-5F71DC3C73F6Q35204641-017434ED-6106-41E1-9FD8-FC1BDAA6FEEAQ35397565-0BF54DE4-3AFB-47AB-A127-121FC374E55CQ35632074-274C1D51-6DFB-4490-BD0B-AEDBF7A01D27Q36154559-727CC2B9-58B9-4777-84C9-334AF06F02C5Q36268446-45753479-93DA-431D-B119-53DE912E066BQ36346099-4626E1C0-9D1F-4550-9DC8-E2E79FB98F0EQ36520006-C009CAE9-8888-4D4D-AC68-C658E446411EQ37250125-43C0DEF7-5D6D-4B94-AA09-ED78BF581B65Q37577995-9F65C43D-EE1A-4942-9355-6717E1C8E585Q37600164-672905DF-D9E5-4FFF-B933-439212A87FBFQ37610944-703FC636-148F-4D7B-84F7-2C220A1BBD13Q37684392-821EEC3B-7DDA-4C1D-BD64-57604468D199Q37974711-E1DA5AC2-85C7-4BE1-B996-12149866833BQ38081246-F204AE58-B10A-4FC4-AA92-970504D08EB9Q38865926-93F4E5B2-E154-4737-AB89-41DEF2C3C549Q38885271-42527C1C-C15E-419A-829A-C688A594EC7FQ40046680-0817AD7D-F954-490F-961D-D928C204232EQ40128647-DF4EC458-8AB5-4998-8FEF-FD059A78412AQ40389262-3C5FA4B2-4DF1-4C4D-9456-1618FC426A7BQ40725718-4952A8C4-1718-41B9-AE0E-9098789EE12B
P2860
The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic
description
1998 nĆ® lÅ«n-bĆ»n
@nan
1998 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
1998 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
1998幓ć®č«ę
@ja
1998幓č«ę
@yue
1998幓č«ę
@zh-hant
1998幓č«ę
@zh-hk
1998幓č«ę
@zh-mo
1998幓č«ę
@zh-tw
1998幓č®ŗę
@wuu
name
The geographical distribution ...... frica before the AIDS epidemic
@ast
The geographical distribution ...... frica before the AIDS epidemic
@en
The geographical distribution ...... frica before the AIDS epidemic
@nl
type
label
The geographical distribution ...... frica before the AIDS epidemic
@ast
The geographical distribution ...... frica before the AIDS epidemic
@en
The geographical distribution ...... frica before the AIDS epidemic
@nl
prefLabel
The geographical distribution ...... frica before the AIDS epidemic
@ast
The geographical distribution ...... frica before the AIDS epidemic
@en
The geographical distribution ...... frica before the AIDS epidemic
@nl
P2093
P2860
P3181
P356
P1476
The geographical distribution ...... frica before the AIDS epidemic
@en
P2093
D P Burkitt
P Cook-Mozaffari
P2860
P2888
P304
P3181
P356
10.1038/BJC.1998.717
P407
P577
1998-12-01T00:00:00Z
P5875
P6179
1044300031